Pharmacoeconomic Evaluation

Pharmacoeconomic Evaluation is a form of health economic evaluation that systematically compares the costs and health outcomes of alternative pharmaceutical interventions, typically using methods such as cost-minimisation, cost-effectiveness, cost-utility, or cost-benefit analysis, in order to inform efficient formulary and resource-allocation decisions.

7.5K

Publications

358.5K

Citations

25.4K

Authors

5.9K

Institutions

Publications per year

2017–2026

2K

Authors

25.4K

  1. AB
    Andrew Briggs

    University of Glasgow, United Kingdom

    56 publications · 9.6K citations

    39

    h-index

  2. MC
    Milton C. Weinstein

    Harvard University, United States

    43 publications · 12.8K citations

    33

    h-index

  3. MD
    Michael Drummond

    University of York, United Kingdom

    55 publications · 7K citations

    32

    h-index

  4. MS
    Mark Sculpher

    University of York, United Kingdom

    41 publications · 8K citations

    31

    h-index

  5. MD
    Michael Drummond

    University of York, United Kingdom

    42 publications · 5.9K citations

    30

    h-index

1–5 of 25.4K

Venues

  1. PubMed

    Repository · 533 publications · 19.5K citations

    62

    h-index

  2. PharmacoEconomics

    298 publications · 11.9K citations

    53

    h-index

  3. Health Economics

    101 publications · 11K citations

    47

    h-index

  4. Value in Health

    190 publications · 8.8K citations

    47

    h-index

  5. BMJ

    64 publications · 8.8K citations

    40

    h-index

1–5